A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer.

Lung cancer (Amsterdam, Netherlands)(2004)

Cited 9|Views9
No score
Abstract
An induction therapy with epoetin alfa 40.000 IU for 2 weeks followed by standard treatment allows an Hb increase of 2.9 g/dL even in advanced lung cancer patients with a moderate/severe anemia, without RBC transfusion requirements. A randomized study of the proposed induction dose of epoetin alfa 40.000 IU is actually ongoing.
More
Translated text
Key words
lung cancer,platinum salts,new regimens,anemia,epoetin alfa 40.000 IU,RBC transfusion,dose intensity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined